Werner Kissling, MD

Original Research

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

February 22, 2011

Johannes Hamann, Rosmarie Mendel, Sarah Reiter, et al

Letter to the Editor

Dr. Hamann and Colleagues Reply

February 14, 2008

Johannes Hamann, Stefan Leucht, Werner Kissling

Original Research

Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment

July 16, 2007

Johannes Hamann, Rudolf Cohen, Stefan Leucht, et al

Original Research

Psychoeducation in Schizophrenia: 7-Year Follow-Up Concerning Rehospitalization and Days in Hospital in the Munich Psychosis Information Project Study

June 15, 2007

Josef Bäuml, Gabriele Pitschel-Walz, Anja Volz, et al

Original Research

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia.

March 15, 2007

Stefan Leucht, Raymonde Busch, Werner Kissling, et al

Original Research

Attitudes of Psychiatrists Toward Antipsychotic Depot Medication

December 15, 2006

Stephan Heres, Johannes Hamann, Werner Kissling, et al

Original Research

Psychoeducation and Compliance in the Treatment of Schizophrenia: Results of the Munich Psychosis Information Project Study.

March 15, 2006

Gabriele Pitschel-Walz, Josef Bäuml, Wolfram Bender, et al

Original Research

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

December 15, 2005

Christine B. Rummel, Wulf-Peter Hansen, Alexandra Helbig, et al

Original Research

Lithium for Schizophrenia Revisited: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

February 1, 2004

Stefan Leucht, Werner Kissling, John McGrath

Original Research

A 28-Week Comparison of Ziprasidone and Haloperidol in Outpatients With Stable Schizophrenia

June 18, 2002

Steven R. Hirsch, Werner Kissling, Josef Bäuml, et al

Original Research

Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence?

March 1, 2002

Stefan Leucht, John McGrath, Paul White, et al

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

Dr. Hamann and Colleagues Reply

Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment

Psychoeducation in Schizophrenia: 7-Year Follow-Up Concerning Rehospitalization and Days in Hospital in the Munich Psychosis Information Project Study

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia.

Attitudes of Psychiatrists Toward Antipsychotic Depot Medication

Psychoeducation and Compliance in the Treatment of Schizophrenia: Results of the Munich Psychosis Information Project Study.

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

Lithium for Schizophrenia Revisited: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A 28-Week Comparison of Ziprasidone and Haloperidol in Outpatients With Stable Schizophrenia

Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence?

ELSEWHERE:

FOLLOW US:

Werner Kissling, MD

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

Dr. Hamann and Colleagues Reply

Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment

Psychoeducation in Schizophrenia: 7-Year Follow-Up Concerning Rehospitalization and Days in Hospital in the Munich Psychosis Information Project Study

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia.

Attitudes of Psychiatrists Toward Antipsychotic Depot Medication

Psychoeducation and Compliance in the Treatment of Schizophrenia: Results of the Munich Psychosis Information Project Study.

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

Lithium for Schizophrenia Revisited: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A 28-Week Comparison of Ziprasidone and Haloperidol in Outpatients With Stable Schizophrenia

Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence?

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles